Literature DB >> 7164137

Haemorrhagic fever in Gabon. I. Incidence of Lassa, Ebola and Marburg viruses in Haut-Ogooué.

B Ivanoff, P Duquesnoy, G Languillat, J F Saluzzo, A Georges, J P Gonzalez, J McCormick.   

Abstract

A serological enquiry aimed at determining the incidence of infection with Lassa, Ebola and Marburg viruses was conducted on the human population of the region of Haut-Ogooué (Gabon) and on primates. The results, obtained by the indirect immunofluorescence technique, showed that more than 6% of the human population had had contact with Ebola virus but no antibodies against Marburg or Lassa viruses were found. Most sera reacted to an Ebola antigen from a Zairian strain, but showed little or no reaction to an antigen from a Sudanese strain.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7164137     DOI: 10.1016/0035-9203(82)90089-x

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN: 0035-9203            Impact factor:   2.184


  8 in total

1.  High prevalence of both humoral and cellular immunity to Zaire ebolavirus among rural populations in Gabon.

Authors:  Pierre Becquart; Nadia Wauquier; Tanel Mahlakõiv; Dieudonné Nkoghe; Cindy Padilla; Marc Souris; Benjamin Ollomo; Jean-Paul Gonzalez; Xavier De Lamballerie; Mirdad Kazanji; Eric M Leroy
Journal:  PLoS One       Date:  2010-02-09       Impact factor: 3.240

2.  Isolation and phylogenetic characterization of Ebola viruses causing different outbreaks in Gabon.

Authors:  M C Georges-Courbot; A Sanchez; C Y Lu; S Baize; E Leroy; J Lansout-Soukate; C Tévi-Bénissan; A J Georges; S G Trappier; S R Zaki; R Swanepoel; P A Leman; P E Rollin; C J Peters; S T Nichol; T G Ksiazek
Journal:  Emerg Infect Dis       Date:  1997 Jan-Mar       Impact factor: 6.883

3.  Risk factors for Marburg hemorrhagic fever, Democratic Republic of the Congo.

Authors:  Daniel G Bausch; Matthias Borchert; Thomas Grein; Cathy Roth; Robert Swanepoel; Modeste L Libande; Antoine Talarmin; Eric Bertherat; Jean-Jacques Muyembe-Tamfum; Ben Tugume; Robert Colebunders; Kader M Kondé; Patricia Pirad; Loku L Olinda; Guénaël R Rodier; Patricia Campbell; Oyewale Tomori; Thomas G Ksiazek; Pierre E Rollin
Journal:  Emerg Infect Dis       Date:  2003-12       Impact factor: 6.883

Review 4.  Outbreaks of Ebola virus disease in Africa: the beginnings of a tragic saga.

Authors:  Jean-Philippe Chippaux
Journal:  J Venom Anim Toxins Incl Trop Dis       Date:  2014-10-03

5.  Integrated biological-behavioural surveillance in pandemic-threat warning systems.

Authors:  Maureen Miller; Emily Hagan
Journal:  Bull World Health Organ       Date:  2016-11-03       Impact factor: 9.408

Review 6.  A systematic review and meta-analysis of seroprevalence surveys of ebolavirus infection.

Authors:  Hilary Bower; Judith R Glynn
Journal:  Sci Data       Date:  2017-01-31       Impact factor: 6.444

7.  Production of monoclonal antibodies and development of an antigen capture ELISA directed against the envelope glycoprotein GP of Ebola virus.

Authors:  Andreas Lucht; Roland Grunow; Christian Otterbein; Peggy Möller; Heinz Feldmann; Stephan Becker
Journal:  Med Microbiol Immunol       Date:  2003-10-31       Impact factor: 4.148

8.  High prevalence of IgG antibodies to Ebola virus in the Efé pygmy population in the Watsa region, Democratic Republic of the Congo.

Authors:  Sabue Mulangu; Matthias Borchert; Janusz Paweska; Antoine Tshomba; Afongenda Afounde; Amayo Kulidri; Robert Swanepoel; Jean-Jacques Muyembe-Tamfum; Patrick Van der Stuyft
Journal:  BMC Infect Dis       Date:  2016-06-10       Impact factor: 3.090

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.